UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000020253
Receipt No. R000023385
Official scientific title of the study Corneal endothelial staining by VisionBlue during DMEK surgery
Date of disclosure of the study information 2016/01/05
Last modified on 2019/01/08 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Corneal endothelial staining by VisionBlue during DMEK surgery
Title of the study (Brief title) Corneal endothelial staining by VisionBlue
Region
Japan

Condition
Condition Bullous keratopathy
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 safety of VisionBlue during DMEK surgery
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes postoperative visual acuity (1W)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver Other
Interventions/Control_1 endothelial sheet was stained by Visoin Blue for 1min during DMEK surgery
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with Bullous keratopathy who was planned to have corneal endothelial transplantation
Key exclusion criteria Patients whom attending doctor decide as unsuitable for DMEK surgery
Target sample size 10

Research contact person
Name of lead principal investigator Tetsuya Kawakita
Organization Keio University School of Medicine
Division name Ophthalmology
Address 35, Shinanomachi, Shinjuku-ku, Tokyo
TEL 03-3353-1211
Email kawakita@a2.keio.jp

Public contact
Name of contact person Tetsuya Kawakita
Organization Keio Univ. School of Medicine
Division name Ophthalmology
Address 35, Shinanomachi, Shinjuku, Tokyo
TEL 03-3353-1211
Homepage URL
Email kawakita@a2.keio.jp

Sponsor
Institute Department of ophthalmology, Keio University School of Medicine
Institute
Department

Funding Source
Organization Department of ophthalmology, Keio University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 01 Month 05 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 10 Month 01 Day
Anticipated trial start date
2016 Year 01 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 17 Day
Last modified on
2019 Year 01 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023385